Concepts (69)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Migraine Disorders | 9 | 2024 | 82 | 4.600 |
Why?
|
| Headache Disorders | 2 | 2022 | 7 | 1.680 |
Why?
|
| Headache | 4 | 2024 | 165 | 1.400 |
Why?
|
| Post-Traumatic Headache | 2 | 2022 | 5 | 0.900 |
Why?
|
| Tension-Type Headache | 1 | 2022 | 1 | 0.870 |
Why?
|
| Biphenyl Compounds | 1 | 2024 | 194 | 0.840 |
Why?
|
| Headache Disorders, Primary | 1 | 2022 | 1 | 0.830 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2020 | 175 | 0.810 |
Why?
|
| Neurofibromatosis 1 | 1 | 2022 | 147 | 0.730 |
Why?
|
| Tuberous Sclerosis | 1 | 2022 | 140 | 0.720 |
Why?
|
| Life Style | 1 | 2024 | 621 | 0.720 |
Why?
|
| Astrocytoma | 1 | 2022 | 327 | 0.670 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2019 | 10 | 0.660 |
Why?
|
| Psychotic Disorders | 1 | 2019 | 154 | 0.580 |
Why?
|
| Disease Management | 1 | 2020 | 1107 | 0.480 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 2492 | 0.420 |
Why?
|
| Pediatrics | 2 | 2018 | 1187 | 0.350 |
Why?
|
| Adolescent | 9 | 2024 | 32262 | 0.240 |
Why?
|
| Brain Neoplasms | 1 | 2022 | 4982 | 0.240 |
Why?
|
| Tetrazoles | 1 | 2024 | 107 | 0.220 |
Why?
|
| Benzimidazoles | 1 | 2024 | 435 | 0.180 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2018 | 19 | 0.160 |
Why?
|
| Child | 7 | 2022 | 30110 | 0.150 |
Why?
|
| Dihydroergotamine | 1 | 2017 | 10 | 0.150 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2018 | 80 | 0.150 |
Why?
|
| Melatonin | 1 | 2017 | 48 | 0.140 |
Why?
|
| Health Surveys | 1 | 2018 | 415 | 0.140 |
Why?
|
| Humans | 13 | 2024 | 269834 | 0.130 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2017 | 132 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2017 | 34218 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2017 | 393 | 0.110 |
Why?
|
| Inpatients | 1 | 2017 | 699 | 0.100 |
Why?
|
| Adult | 4 | 2022 | 80478 | 0.100 |
Why?
|
| Telemedicine | 1 | 2018 | 538 | 0.100 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 15183 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 1219 | 0.070 |
Why?
|
| Risk Factors | 1 | 2024 | 18032 | 0.070 |
Why?
|
| Time Factors | 1 | 2020 | 13246 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 4452 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2024 | 39453 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2018 | 16744 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2018 | 2361 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2018 | 2863 | 0.050 |
Why?
|
| Patient Selection | 2 | 2018 | 2115 | 0.040 |
Why?
|
| Contraindications, Drug | 1 | 2018 | 4 | 0.040 |
Why?
|
| Cluster Headache | 1 | 2018 | 3 | 0.040 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2018 | 182 | 0.040 |
Why?
|
| Body Size | 1 | 2018 | 68 | 0.040 |
Why?
|
| Male | 5 | 2019 | 127192 | 0.040 |
Why?
|
| Lidocaine | 1 | 2017 | 78 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 254 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 417 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2017 | 382 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 537 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2018 | 579 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2018 | 13286 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2018 | 813 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 2656 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 5019 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 4360 | 0.020 |
Why?
|
| Young Adult | 2 | 2018 | 22111 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 3837 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 3362 | 0.020 |
Why?
|
| Incidence | 1 | 2017 | 5874 | 0.020 |
Why?
|
| Female | 4 | 2018 | 146824 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 7819 | 0.020 |
Why?
|
| Animals | 1 | 2018 | 60903 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 72701 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 89237 | 0.010 |
Why?
|